Table 3.
Marker | Patients with columnar metaplasia with goblet cells (Barrett’s Esophagus) | Patients with columnar metaplasia without goblet cells | Gastric Controls | ||
---|---|---|---|---|---|
LDGC N=25 | HDGC N=34 | Total N=59 | N=30 | N= 19 | |
MUC5AC | 25 (100%) | 34 (100%) | 59 (100%) | 30 (100%) | 19 (100%) |
MUC2 | 18 (72%)c | 32 (94%)c | 50 (85%) | 0 (0%) | 0 |
Das-1 | 21 (84%) | 32 (94%) | 53 (90%) | 9 (30%) | 0 |
Villin | 23 (92%) | 33 (97%) | 56 (95%) | 5 (17%) | 0 |
CDX-2 | 24 (96%) | 34 (100%) | 58 (98%) | 13 (43%) | 0 |
Ki67 | 12 (48%)a | 25 (74%)b | 37 (63%) | 5 (17%)a,b | 0 |
LDGC = low density goblet cells, HDGC = high density goblet cells, N = number of patients
p<0.02
p<0.0007
p<0.03